DMAC DiaMedica Therapeutics Inc.: institutional ownership and insider trading
93 funds reported holding $99.7M of DiaMedica Therapeutics Inc. in their latest 13F filings; in Q2 2026 funds net bought $11.3M, with 10 new positions and 19 funds selling out; over the last 12 months insiders bought $7.63M and sold $0 on the open market.
Famous investors holding DMAC
- Izzy Englander (Millennium Management): $5.95M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $1.03M, 0.0% of the portfolio
Largest institutional holders of DMAC
- COOPERMAN LEON G — $24.3M
- BlackRock, Inc. (BLK) — $15.9M
- GEODE CAPITAL MANAGEMENT, LLC — $6.30M
- MILLENNIUM MANAGEMENT LLC — $5.95M
- PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE — $5.92M
- VANGUARD GROUP INC — $5.76M
- STATE STREET CORP (STT, STT-PG) — $4.55M
- Bleichroeder LP — $2.69M
- VANGUARD CAPITAL MANAGEMENT LLC — $2.50M
- OSAIC HOLDINGS, INC. — $2.38M
Recent DMAC insider trades
- Nov 25, 2025: Trill Ab bought 1,061,277 shares ($7.63M)
- Aug 27, 2025: Trill Ab bought 1,000,000 shares ($5.96M)
- Jul 23, 2025: Jacinto Richard Ii bought 400,000 shares ($1.40M)
- Jul 23, 2025: Trill Ab bought 1,542,857 shares ($5.40M)
5%+ owners
- TRILL AB: 16.9% (Schedule 13G/A, filed Feb 6, 2026)
- TomEnterprise AB: 16.3% (Schedule 13G/A, filed Jul 30, 2025)
- Richard Jacinto II: 9.6% (Schedule 13G/A, filed Nov 7, 2025)
- Cooperman Leon G.: 6.6% (Schedule 13G/A, filed Feb 17, 2026)